Skip to main content
Equibles

Parallel Advisors, LLC

Position in AMRN — Amarin Corp Plc\Uk

CIK 1690010 SAN FRANCISCO, CA
Back to AMRN Full portfolio

Position in AMRN

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$159
+$15 QoQ
Shares Held
10
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 80 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in AMRN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $119,634,223 across 18 Drug Manufacturers - General names. AMRN ranks #17 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 31,933 $38,301,401
2 ABBV
AbbVie Inc.
 100,846 $25,376,887
3 JNJ
Johnson & Johnson
 83,035 $21,088,398
4 GILD
Gilead Sciences, Inc.
 76,862 $9,710,745
5 MRK
Merck & Co., Inc.
 66,774 $8,580,459
6 AMGN
Amgen Inc
 11,139 $4,033,654
7 NVO
Novo Nordisk A S
 56,877 $2,726,683
8 NVS
Novartis AG
 15,640 $2,451,100

All Filings in AMRN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $159 10
2026-03-31 $144 10
2025-12-31 $139 10
2025-09-30 $163 10
2025-06-30 $162 10
2025-03-31 $90 200
2024-12-31 $98 200
2024-09-30 $126 200
2024-06-30 $138 200
2024-03-31 $178 200
2023-12-31 $174 200
2023-09-30 $184 200
2023-06-30 $238 200
2023-03-31 $300 200
2022-12-31 $242 200
2022-09-30 $1,754 1,610
2022-06-30 $1,154 775
2022-03-31 $658 200
2021-12-31 $674 200
2021-09-30 $1,020 200
2021-06-30 $1,314 300
2021-03-31 $1,242 200
2020-12-31 $8,420 1,722
2020-09-30 $7,670 1,822
2020-06-30 $12,608 1,822
2020-03-31 $7,288 1,822